IDEAYA Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $100.0M | $298.3M | $72.0M |
| FY2021 | $79.8M | $381.3M | $92.0M |
| FY2022 | $38.5M | $388.0M | $68.6M |
| FY2023 | $28.2M | $649.3M | $157.0M |
| FY2024 | $64.9M | $1.12B | $84.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $100.0M | $298.3M | $72.0M |
| FY2021 | $79.8M | $381.3M | $92.0M |
| FY2022 | $38.5M | $388.0M | $68.6M |
| FY2023 | $28.2M | $649.3M | $157.0M |
| FY2024 | $64.9M | $1.12B | $84.4M |